BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8509385)

  • 21. Rat striatal acetylcholinesterase inhibition by fasciculin (a polypeptide from green mamba snake venom).
    Dajas F; Bolioli B; Castello ME; Silveira R
    Neurosci Lett; 1987 Jun; 77(1):87-91. PubMed ID: 3601220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding sites of inhibitory monoclonal antibodies on acetylcholinesterase. Identification of a novel regulatory site at the putative "back door".
    Simon S; Le Goff A; Frobert Y; Grassi J; Massoulié J
    J Biol Chem; 1999 Sep; 274(39):27740-6. PubMed ID: 10488117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple binding of D-tubocurarine to acetylcholinesterase.
    Zorko M; Pavlic MR
    Biochem Pharmacol; 1986 Jul; 35(14):2287-96. PubMed ID: 3729986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
    Radić Z; Kirchhoff PD; Quinn DM; McCammon JA; Taylor P
    J Biol Chem; 1997 Sep; 272(37):23265-77. PubMed ID: 9287336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoacetylcholinesterase: toxicity of phosphorus oxychloride to mammals and insects that can be attributed to selective phosphorylation of acetylcholinesterase by phosphorodichloridic acid.
    Quistad GB; Zhang N; Sparks SE; Casida JE
    Chem Res Toxicol; 2000 Jul; 13(7):652-7. PubMed ID: 10898598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
    Bui JM; Radic Z; Taylor P; McCammon JA
    Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular properties and inhibition kinetics of acetylcholinesterase obtained from rat brain and cockroach ganglion.
    Singh AK
    Toxicol Ind Health; 1990 Dec; 6(6):551-70. PubMed ID: 2097819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
    Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
    J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of non-critical binding proteins in the sensitivity of acetylcholinesterase from different species to diisopropyl fluorophosphate (DFP), in vitro.
    Wang C; Murphy SD
    Life Sci; 1982 Jul; 31(2):139-49. PubMed ID: 7121200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular determinants of the species-selective inhibition of brain acetylcholinesterase.
    Kemp JR; Wallace KB
    Toxicol Appl Pharmacol; 1990 Jun; 104(2):246-58. PubMed ID: 2363176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of monoclonal antibodies that strongly inhibit Electrophorus electricus acetylcholinesterase.
    Remy MH; Frobert Y; Grassi J
    Eur J Biochem; 1995 Aug; 231(3):651-8. PubMed ID: 7649165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of arginine residues for the activity of fasciculin.
    Cervenanský C; Engström A; Karlsson E
    Eur J Biochem; 1995 Apr; 229(1):270-5. PubMed ID: 7744040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energetics of ligand and inhibitor interactions with acetylcholinesterase.
    Das YT; Brown HD; Chattopadhyay SK
    Biochem Cell Biol; 1987 Sep; 65(9):798-802. PubMed ID: 3440086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region.
    Bourne Y; Renault L; Essono S; Mondielli G; Lamourette P; Boquet D; Grassi J; Marchot P
    PLoS One; 2013; 8(10):e77226. PubMed ID: 24146971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands.
    Jerusalinsky D; Cerveñasky C; Peña C; Raskovsky S; Dajas F
    Neurochem Int; 1992 Feb; 20(2):237-46. PubMed ID: 1304863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a noncholinergic function of acetylcholinesterase during development of chicken retina as shown by fasciculin.
    Blasina MF; Faria AC; Gardino PF; Hokoc JN; Almeida OM; de Mello FG; Arruti C; Dajas F
    Cell Tissue Res; 2000 Feb; 299(2):173-84. PubMed ID: 10741458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inhibitory monoclonal antibody to rabbit brain acetylcholinesterase. Studies on interaction with the enzyme.
    Brimijoin S; Mintz KP; Prendergast FG
    Mol Pharmacol; 1985 Dec; 28(6):539-45. PubMed ID: 4079910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitors.
    Weiner L; Shnyrov VL; Konstantinovskii L; Roth E; Ashani Y; Silman I
    Biochemistry; 2009 Jan; 48(3):563-74. PubMed ID: 19115961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.